Are Allergy Drops FDA-Approved? Regulatory Facts | Curex

Quick Answer

Four sublingual immunotherapy (SLIT) tablets have full FDA approval: Grastek (grass, April 2014), Ragwitek (ragweed, April 2014), Odactra (house dust mite, March 2017), and Oralair (5-grass, April 2014). Custom multi-allergen allergy drops — the kind used by most telehealth allergy providers — are prescribed off-label. Off-label prescribing is legal in all 50 states and accounts for roughly 21% of all US outpatient prescriptions (AHRQ).

Quick Facts

Detail	Info
FDA-approved SLIT products	4 tablets: Grastek, Ragwitek, Odactra, Oralair (2014–2017)
Custom multi-allergen drops	Off-label — no FDA approval pathway exists for custom formulations
Off-label prescribing in US	~21% of all outpatient prescriptions (AHRQ)
AAAAI/ACAAI 2017 position	Recommends ONLY FDA-approved SLIT tablets; off-label drops "not systematically studied in a rigorous manner"
US allergist SLIT adoption	5.9% (2007) → 73% (2018)
FDA tablets with copay card	$25–35/month; custom drops = $39–99/month; retail without insurance = $350–490/month (2026)

"Are Allergy Drops FDA-Approved or Am I Taking Something Unregulated?"

You're holding a small bottle of liquid under your tongue every morning. Your allergist prescribed it. But when you Google "are allergy drops FDA approved," the answers contradict each other. Some sites say yes. Some say no. Your insurance company says they won't cover it. Your friend's allergist says they're not proven.

The confusion isn't your fault. The answer genuinely depends on which product you're talking about, and the distinction matters for your wallet, your insurance claims, and your expectations.

Why This Happens

Step 1 — The FDA approves products, not therapies. The FDA cannot approve "sublingual immunotherapy" as a concept. It approves specific manufactured products with defined formulations, clinical trial data, and consistent dosing. Custom multi-allergen drops are mixed by compounding pharmacies for individual patients — each formula is different, which means no single product exists to submit for approval.

Step 2 — Four single-allergen tablets cleared the regulatory bar. Grastek, Ragwitek, Odactra, and Oralair each went through Phase III trials with thousands of patients. In Europe, SLIT has been approved since 2004, and additional products like Itulazax (birch/tree pollen) are approved in 22+ EU countries with Phase III data showing a 40% reduction in total combined symptom scores (Biedermann 2019, N=634). No US Biologics License Application has been filed for Itulazax.

Step 3 — Custom drops fall into a compounding gray zone. The FDA's 2018 enforcement discretion guidance mentions only "subcutaneous immunotherapy" — not sublingual. Compounding pharmacies operate under state pharmacy boards, not direct FDA product approval. This is legal, but it means custom multi-allergen drops lack the controlled trial data that FDA-approved tablets have. The World Allergy Organization states that for multi-allergen SLIT, "claims for efficacy are unjustified" — a limitation you should know about.

What To Do Next

Step 1 — Check if an FDA-approved tablet covers your allergen. If your primary trigger is grass, ragweed, or dust mites, an FDA-approved tablet exists. With manufacturer copay cards, cost drops to $25–35/month, and insurance pharmacy benefits typically cover them with prior authorization.

Step 2 — Understand what off-label means for your specific situation. If you're allergic to cats, mold, trees, or multiple allergens simultaneously, no FDA-approved SLIT product exists for those triggers. Custom drops prescribed off-label by a licensed physician are the available sublingual option. Off-label prescribing is standard medical practice — roughly 21% of all US outpatient prescriptions are off-label (AHRQ).

Step 3 — Know your triggers before choosing a path. A comprehensive allergy test identifies exactly which allergens drive your symptoms, which determines whether an FDA-approved option exists for you.

Take the free 3-minute allergy quiz →

When FDA Approval Should Drive Your Decision

If your primary need is insurance coverage, FDA-approved tablets are the only SLIT option that major insurers will pay for. Custom multi-allergen drops have no insurance coverage from any major US insurer, and the AAAAI does not endorse off-label drops. If you have a $0 specialist copay and an allergist nearby, FDA-approved tablets or traditional allergy shots may cost you less out of pocket. Custom drops make more sense when you have multiple allergens not covered by any approved tablet, when office visits are impractical, or when you've already tried and quit shots.

Related Issues to Check

How sublingual immunotherapy works — Understanding the immune mechanism is the same whether drops are FDA-approved or off-label. The sublingual tissue's tolerogenic dendritic cells don't check regulatory status.
Allergy drops vs allergy shots — Shots (SCIT) have decades of FDA-approved data. If regulatory confidence matters most to you, this comparison helps weigh that against convenience and safety differences.
Does insurance cover allergy drops? — The FDA approval gap directly determines your payment options. FDA tablets get pharmacy coverage; custom drops don't. HSA/FSA covers both.

Frequently Asked Questions

Are custom allergy drops illegal? No. Off-label prescribing is legal in all 50 states. Approximately 21% of all US outpatient prescriptions are off-label (AHRQ). The physician takes responsibility for clinical judgment.

Why doesn't the FDA just approve multi-allergen drops? The FDA approves specific manufactured products with standardized formulations. Custom drops are mixed individually by compounding pharmacies — each patient gets a different combination. There is no single product to submit for approval.

What does the AAAAI say about off-label drops? The AAAAI/ACAAI 2017 practice parameter recommends ONLY FDA-approved SLIT tablets and states that off-label drops have "not been systematically studied in a rigorous manner." This is the major allergy specialty organization's current official position.

Do European approvals mean anything for the US? Europe has approved SLIT since 2004 and has more products available. Itulazax (birch/tree pollen) is approved in 22+ EU countries. However, European approval does not transfer to the US — each product requires separate FDA review.

Is there a non-responder rate for allergy drops? Yes. Approximately 20–30% of patients do not respond to immunotherapy regardless of the delivery method (Gotoh 2017). This applies to both FDA-approved tablets and custom drops.

Can my allergist prescribe FDA-approved tablets instead of custom drops? Yes, if your primary allergen matches one of the four approved products (grass, ragweed, dust mite). Ask specifically about Grastek, Ragwitek, Odactra, or Oralair. These come with insurance coverage and manufacturer copay cards.

Last reviewed: March 2026 · Sources verified against current data

Medically reviewed by Dr. Chet Tharpe, MD · March 2026

Take the Next Step

Knowing your specific allergens determines whether an FDA-approved option exists for you or whether custom drops are the better path. A 3-minute quiz identifies your triggers and matches you to the right treatment category.